Ion Exchange (India)
- P/E
- 46.93
Key Fundamentals
MicrocapOther UtilitiesUtilitiesPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.20%
- Debt to Equity
- 0.36
- EPS (TTM)
- ₹6.69
- Book Value
- ₹91.33
- Market Cap
- —
- P/E (TTM)
- 46.93
- P/B
- 3.44
- ROE
- 12.00%
- Dividend Yield
- 0.37%
- EBITDA
- ₹297 Cr
- 52W High
- ₹486.00
- 52W Low
- ₹295.00
- Volume
- 0
Peer Comparison
Utilities › Water Supply & Management
| ₹1,854.60 | 29.26 | ₹11,480 Cr | 4.51 | 0.28% | 15.90% | 21.30% | ₹4,097 Cr | ₹394 Cr | |
| ₹313.95 | 46.93 | ₹4,372 Cr | 3.44 | 0.37% | 12.00% | 14.20% | ₹3,032 Cr | ₹98 Cr | |
| ₹179.55 | 17.42 | ₹3,055 Cr | 2.62 | 0.00% | 16.80% | 20.20% | ₹1,264 Cr | ₹191 Cr | |
| ₹540.20 | 37.26 | ₹2,070 Cr | 5.86 | 0.00% | — | — | ₹325 Cr | ₹44 Cr | |
| ₹270.60 | — | ₹697 Cr | — | 0.00% | — | 15.40% | ₹2,922 Cr | −₹7 Cr | |
| ₹240.29 | 11.99 | ₹624 Cr | 1.40 | 1.11% | 13.30% | 18.40% | ₹242 Cr | ₹53 Cr | |
| ₹241.05 | — | ₹317 Cr | 5.02 | 0.00% | 31.10% | 41.40% | — | — | |
| Median 7 companies | ₹270.60 | 29.26 | ₹2,070 Cr | 3.98 | 0.00% | 15.90% | 19.30% | ₹2,093 Cr | ₹75 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 26
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 43
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 39
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 16
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 69
- Strong
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
3- Promoter holding is low: 25.4%
- Company might be capitalizing the interest cost
- Dividend payout has been low at 11.2% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 4 | 3 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 24.08
- Bullish
- MACD (12,26,9)
- −19.11
- Bearish
- SMA (50)
- 389.61
- Bearish
- SMA (200)
- 383.27
- Bearish
As of
Analyst Rating
1 of 1 analyst rates Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +12.88% |
|---|---|
| 5Y | +14.99% |
| 3Y | +13.57% |
| 1Y | +6.50% |
| TTM | +10.15% |
Net profit
| 10Y | +23.73% |
|---|---|
| 5Y | 0.00% |
| 3Y | −9.82% |
| 1Y | −31.25% |
| TTM | −53.83% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.66 pp |
|---|---|
| 5Y | −6.94 pp |
| 3Y | −5.62 pp |
| 1Y | −3.51 pp |
| TTM | −4.70 pp |
Revenue by year
| Mar 2017 | ₹1,009 Cr |
|---|---|
| Mar 2018 | ₹1,046 Cr |
| Mar 2019 | ₹1,162 Cr |
| Mar 2020 | ₹1,480 Cr |
| Mar 2021 | ₹1,450 Cr |
| Mar 2022 | ₹1,577 Cr |
| Mar 2023 | ₹1,990 Cr |
| Mar 2024 | ₹2,348 Cr |
| Mar 2025 | ₹2,737 Cr |
| Mar 2026 | ₹2,915 Cr |
Net profit by year
| Mar 2017 | ₹29.00 Cr |
|---|---|
| Mar 2018 | ₹40.00 Cr |
| Mar 2019 | ₹66.00 Cr |
| Mar 2020 | ₹94.00 Cr |
| Mar 2021 | ₹143 Cr |
| Mar 2022 | ₹162 Cr |
| Mar 2023 | ₹195 Cr |
| Mar 2024 | ₹195 Cr |
| Mar 2025 | ₹208 Cr |
| Mar 2026 | ₹143 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Ion Exchange (India) Ltd trades at a market cap of ₹6,208 Cr with a PE of 42.7x despite a TTM profit decline of 26% and FY26 PAT margin compression to ~4.9%. The company has a strong long-term revenue CAGR of 13% over 10 years and operates in a structurally growing water treatment sector, but near-term profitability is under significant pressure from legacy project costs and margin erosion.
- 10-year compounded profit CAGR of 26% demonstrates long-term earnings power and scalability of the business model
- 10-year compounded sales CAGR of 13% and 5-year sales CAGR of 15% reflect consistent top-line growth in a secular demand environment
- Jal Jeevan Mission allocation of ₹67,670 Cr in FY27 budget — nearly 4x the FY26 revised estimate — provides a massive addressable opportunity for water treatment players
- Recent international order win of $52.83 million (~₹503 Cr) from Hyundai Engineering signals growing export competitiveness and order book diversification
- FY26 full-year revenue grew 7% YoY to ₹2,915 Cr, showing resilience in top-line despite margin headwinds
- 5-year ROE average of 20% and 10-year ROE average of 22% indicate historically efficient capital deployment
- Roha manufacturing plant commissioning expected to drive chemical segment growth and improve margins once fully ramped up
- 10-year stock CAGR of 29% reflects substantial long-term wealth creation track record
- TTM profit declined 26% with Q4 FY26 net profit crashing 62% YoY to ₹24.1 Cr, indicating severe near-term earnings deterioration
- PE ratio of 42.7x is elevated relative to the compressed TTM earnings, implying the stock prices in a recovery that is not yet visible in results
- FY26 PAT margin fell to ~4.9% for the full year, with Q4 FY26 PAT margin at just 2.8% and EBITDA margin at 2.3%, reflecting deep margin erosion
- Promoter holding is low at 25.4%, which limits promoter alignment and increases vulnerability to market volatility or hostile actions
- Last year ROE dropped to 12% from a 3-year average of 17%, signaling deteriorating return on equity
- Dividend payout has been low at 11.2% of profits over the last 3 years with a current yield of just 0.3%, offering minimal income support
- Company might be capitalizing interest costs, which could overstate reported asset values and understate true operating expenses
- 1-year stock return of -10% and 3-year CAGR of -7% show the market has de-rated the stock amid earnings disappointment
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Ion Exchange has secured a significant international order worth $52.83M for filtration units in the Middle East, reinforcing its export capabilities and order book strength. No notable headwinds emerged in the period. The trend is positive with fresh order inflow providing revenue visibility over the next 18 months.
- $52.83M Middle East order win Jul 10
Ion Exchange secured a USD 52.83 million contract from Hyundai Engineering for filtration units in the Middle East, with execution timeline of 18 months.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 479 | 533 | 554 | 782 | 568 | 644 | 691 | 835 | 583 | 734 | 734 | 863 | 700 | 675 |
| Expenses | 430 | 473 | 483 | 690 | 503 | 576 | 615 | 749 | 521 | 665 | 675 | 844 | 669 | 759 |
| Operating Profit | 48.78 | 60.39 | 70.58 | 91.99 | 64.21 | 68.3 | 75.47 | 85.74 | 62.54 | 68.49 | 59.25 | 19.74 | 31.74 | −84.76 |
| OPM % | 10.18% | 11.33% | 12.74% | 11.77% | 11.31% | 10.6% | 10.93% | 10.27% | 10.72% | 9.33% | 8.07% | 2.29% | 4.53% | −12.56% |
| Other Income | 8.69 | 10.65 | 9.44 | 16.85 | 11.43 | 14.53 | 8.91 | 14.84 | 18.2 | 14.62 | −4.43 | 43.13 | 6.36 | 8.71 |
| Interest | 2.05 | 3.56 | 3.22 | 3.23 | 2.93 | 3.62 | 3.3 | 3.61 | 2.56 | 3.08 | 7.57 | 10.79 | 8.95 | 9.42 |
| Depreciation | 7.87 | 8.5 | 9.62 | 10.42 | 10.44 | 10.89 | 11.33 | 11.83 | 12.26 | 12.17 | 18.57 | 19.6 | 21.75 | 22 |
| PBT | 47.55 | 58.98 | 67.18 | 95.19 | 62.27 | 68.32 | 69.75 | 85.14 | 65.92 | 67.86 | 28.68 | 32.48 | 7.4 | −107 |
| Tax % | 29.93% | 28.2% | 29.68% | 23.89% | 28.09% | 25.88% | 28.9% | 25.72% | 26.52% | 26.44% | 28.31% | 25.22% | 58.65% | −22.99% |
| Net Profit | 33.32 | 42.35 | 47.24 | 72.45 | 44.78 | 50.64 | 49.59 | 63.24 | 48.44 | 49.92 | 20.56 | 24.29 | 3.06 | −82.76 |
| EPS (₹) | 2.27 | 2.9 | 3.24 | 4.96 | 3.07 | 3.47 | 3.31 | 4.32 | 3.32 | 3.38 | 1.38 | 1.65 | 0.28 | — |
Sep 2026: from the results filed on 3 Nov 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 798 | 868 | 1,009 | 1,046 | 1,162 | 1,480 | 1,450 | 1,577 | 1,990 | 2,348 | 2,737 | 2,915 | 3,032 |
| Expenses | 750 | 810 | 935 | 966 | 1,053 | 1,342 | 1,243 | 1,361 | 1,731 | 2,072 | 2,440 | 2,701 | 2,853 |
| Operating Profit | 49 | 58 | 74 | 80 | 109 | 138 | 207 | 216 | 258 | 275 | 297 | 214 | 179 |
| OPM % | 6% | 7% | 7% | 8% | 9% | 9% | 14% | 14% | 13% | 12% | 11% | 7% | 6% |
| Other Income | 4 | 7 | 12 | 21 | 34 | 36 | 31 | 42 | 42 | 45 | 49 | 71 | 60 |
| Interest | 17 | 17 | 21 | 22 | 21 | 19 | 15 | 13 | 12 | 15 | 17 | 28 | 30 |
| Depreciation | 12 | 13 | 12 | 13 | 20 | 24 | 28 | 28 | 29 | 36 | 44 | 63 | 72 |
| PBT | 24 | 35 | 54 | 66 | 102 | 131 | 195 | 217 | 259 | 269 | 285 | 195 | 136 |
| Tax % | 52% | 51% | 46% | 40% | 35% | 28% | 27% | 26% | 25% | 27% | 27% | 27% | — |
| Net Profit | 11 | 17 | 29 | 40 | 66 | 94 | 143 | 162 | 195 | 195 | 208 | 143 | 98 |
| EPS (₹) | 0.67 | 1.05 | 2.07 | 2.74 | 4.45 | 6.38 | 9.81 | 11.1 | 13.41 | 13.37 | 14.17 | 9.73 | 6.69 |
| Div. Payout % | 43% | 28% | 16% | 12% | 10% | 9% | 10% | 9% | 9% | 11% | 10% | 12% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 142 | 156 | 153 | 186 | 246 | 349 | 492 | 641 | 819 | 1,004 | 1,194 | 1,325 |
| Borrowings | 86 | 90 | 111 | 165 | 110 | 122 | 62 | 55 | 59 | 152 | 323 | 482 |
| Other Liabilities | 437 | 456 | 689 | 699 | 795 | 896 | 875 | 914 | 1,047 | 1,271 | 1,449 | 1,550 |
| Total Liabilities | 679 | 715 | 967 | 1,064 | 1,164 | 1,382 | 1,443 | 1,625 | 1,939 | 2,441 | 2,979 | 3,371 |
| Fixed Assets | 85 | 103 | 99 | 145 | 161 | 194 | 190 | 192 | 215 | 367 | 392 | 753 |
| CWIP | 14 | 2 | 34 | 7 | 12 | 12 | 15 | 20 | 42 | 61 | 323 | 176 |
| Investments | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 9 | 10 | 12 | 13 | 16 |
| Other Assets | 578 | 608 | 831 | 909 | 987 | 1,172 | 1,234 | 1,404 | 1,672 | 2,001 | 2,250 | 2,427 |
| Total Assets | 679 | 715 | 967 | 1,064 | 1,164 | 1,382 | 1,443 | 1,625 | 1,939 | 2,441 | 2,979 | 3,371 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 45 | 50 | 176 | 86 | 127 | 102 | 197 | 91 | 63 | 130 | 32 | −28 |
| Investing | −17 | −25 | −75 | −167 | −70 | −17 | −27 | −93 | −41 | −160 | −165 | −36 |
| Financing | −29 | −17 | −3 | 31 | −79 | −28 | −75 | −27 | −15 | 8 | 128 | 100 |
| Net Cash Flow | −1 | 8 | 98 | −50 | −22 | 56 | 96 | −28 | 6 | −22 | −4 | 35 |
| Free Cash Flow | 29 | 21 | 132 | 57 | 96 | 70 | 167 | 42 | 3 | 10 | −287 | −280 |
| CFO/EBITDA | 113 | 111 | 270 | 143 | 147 | 100 | 119 | 75 | 53 | 74 | 35 | 17 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 164 | 153 | 151 | 153 | 133 | 124 | 113 | 118 | 128 | 145 | 148 | 135 |
| Inventory Days | 55 | 53 | 68 | 55 | 65 | 51 | 52 | 70 | 65 | 59 | 63 | 87 |
| Days Payable | 221 | 215 | 206 | 197 | 207 | 188 | 219 | 202 | 162 | 174 | 165 | 177 |
| Cash Conversion Cycle | −2 | −9 | 12 | 11 | −9 | −13 | −54 | −14 | 31 | 31 | 46 | 44 |
| Working Capital Days | 5 | 3 | −48 | −72 | −64 | −51 | −53 | −27 | 5 | 16 | 33 | 53 |
| ROCE % | 16% | 20% | 27% | 27% | 33% | 35% | 40% | 36% | 34% | 27% | 22% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ion Exchange insights
62 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT
- Q1 FY27 concall · Aug 2026PPT
- Concall · Aug 2026PPT
- Q4 FY26 concall · Jun 2026Transcript PPT Recording
- 4 Nov 2025
- 20 Mar 2026
- 17 Mar 2026
- 17 Dec 2024
- 3 Oct 2023
- 7 Jul 2022
- General announcements 29 Oct 2026
- General announcements 28 Oct 2026
Frequently Asked Questions about Ion Exchange (India)
What does Ion Exchange (India) Ltd do?
Where is Ion Exchange (India) Ltd (IONEXCHANG) listed?
Which sector does Ion Exchange (India) Ltd belong to?
What is the PE ratio of Ion Exchange (India) Ltd?
What is the 52-week high and low of Ion Exchange (India) Ltd?
Does Ion Exchange (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Ion Exchange (India) Ltd?
Company Information
Ion Exchange (India) is engaged in a wide range of solutions across the water cycle from pre-treatment to process water treatment, waste water treatment, recycle, zero liquid discharge, sewage treatment, packaged drinking water, sea water desalination etc.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IONEXCHANG.md for Ion Exchange (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.